Atomico's Investment in Pomelo Care: Setting a New Standard for Women's and Children's Healthcare
TLDR
- Atomico joins Pomelo Care’s $92M Series C at a $1.7B valuation; the virtual maternity care company covers 25M+ lives and reports a 37% reduction in preterm births.
Key Takeaways
- Pomelo Care was founded in 2021 by Marta Bralic Kerns, formerly of Flatiron Health (acquired by Roche for $1.9B), and has scaled to cover more than 25 million lives.
- Clinical outcomes published at peer-reviewed conferences include a 6.8-day reduction in NICU stay length, 37% fewer preterm births, and 46% lower ER utilization.
- The business model is value-based virtual care: patients get a 24/7 multispecialty team (nurses, dietitians, therapists, doulas) via phone, text, and video, paired with predictive analytics embedded in clinician workflows.
- Customers see a reported 3-5x ROI through reduced NICU, ER, and preterm birth costs; the US spends over $100B annually on maternity and NICU care.
- Series C proceeds will expand beyond maternity into reproductive care, pediatrics, hormonal health, perimenopause, menopause, and long-term preventive care.
Why It Matters
- 1 in 10 US babies enters the NICU at an average cost of $6,000 per day; Pomelo’s model targets the maternal health factors that cause many of those admissions.
- Publishing claims-based outcomes at scientific conferences is unusual in digital health and sets a higher accountability bar for the category.
- Scaling a value-based virtual care model to 25M covered lives in under five years suggests employer and health plan distribution is the viable go-to-market path for maternal health at national scale.
Atomico · 2026-01-08 · Read the original
